Brought to you by 
NicOx completes FOPO on Nouveau Marche
11 Jun 2001
Executive Summary
NicOx SA (nitric oxide-based drugs) netted approximately $49mm (Euro55.4mm) (including the 153k share overallotment) in a follow-on offering of 870k shares priced at $60.14 (Euro68.20) apiece to international institutional investors and to the French public. Selling shareholders sold an additional 150k shares.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
NicOx completes FOPO on Nouveau Marche
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice